Freestone Grove Partners LP Makes New $1.29 Million Investment in The Cooper Companies, Inc. $COO

Freestone Grove Partners LP bought a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 18,013 shares of the medical device company’s stock, valued at approximately $1,292,000.

A number of other hedge funds have also modified their holdings of the company. Jupiter Topco LLC bought a new position in Cooper Companies during the second quarter worth about $305,074,000. Hsbc Holdings PLC acquired a new position in Cooper Companies during the second quarter valued at approximately $30,678,000. Ancora Advisors LLC bought a new position in shares of Cooper Companies in the second quarter valued at $2,394,000. Expect Equity LLC bought a new position in shares of Cooper Companies in the 2nd quarter valued at about $3,015,000. Finally, Legal & General Group Plc bought a new position in Cooper Companies during the second quarter worth about $60,521,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

COO has been the topic of several research reports. Stifel Nicolaus decreased their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a research note on Wednesday, May 27th. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. Finally, Wells Fargo & Company reaffirmed a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Stock Up 0.3%

Shares of NASDAQ:COO opened at $71.17 on Friday. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The business’s 50-day moving average is $72.56 and its 200-day moving average is $70.88. The company has a market capitalization of $13.88 billion, a price-to-earnings ratio of 60.31, a P/E/G ratio of 1.86 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.